TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases

1994 Wang, 1996, The p21RAS tarnesyltransferase alpha subunit in TGF-β and activin signaling, Science, 271, 1120, 10.1126/science.271.5252.1120 Wang, 1996, The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type 1 receptors, Cell, 86, 435, 10.1016/S0092-8674(00)80116-6 Massague, 1996, TGFβ signaling: receptors, transducers, and MAD proteins, Cell, 85, 947, 10.1016/S0092-8674(00)81296-9 Lawrence, 1996, Transforming growth factor-β: a general review, Eur Cytokine Nem, 7, 363 Saltis, 1996, TGF-beta: receptors and cell cycle arrest, Mol Cell Endocrinol, 116, 227, 10.1016/0303-7207(95)03721-7 Grande, 1997, Role of transforming growth factor-β in tissue injury and repair, 214, 27 Flanders, 1993, Effects of TFG-β's and bFGF on astroglial cell growth and gene expression in vitro, Mol Cell Neurosci, 4, 406, 10.1006/mcne.1993.1051 Unsicker, 1991, Transforming growth factor β isoforms in the adult rat central and peripheral nervous system, Neuroscience, 44, 613, 10.1016/0306-4522(91)90082-Y da Cunha, 1993, Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex, J Neuroimmunol, 42, 71, 10.1016/0165-5728(93)90214-J O'Brien, 1994, Astrocyte response and transforming growth factor-β localization in acute spinal cord injury, Spine, 19, 2321, 10.1097/00007632-199410150-00012 da Cunha, 1993, Control of astrocytosis by interleukin-1 and transforming growth factor-β1 in human brain, Brain Res, 631, 39, 10.1016/0006-8993(93)91183-S Knuckey, 1996, Differential neuronal and astrocytic expression of transforming growth factor β isoforms in rat hippocampus following transient forebrain ischemia, Mol Brain Res, 40, 1 Laping, 1994, Transforming growth factor β induces neuronal and astrocyte genes: Tubulin alpha 1, glial fibrillary acidic protein and clusterin, Neuroscience, 58, 563, 10.1016/0306-4522(94)90081-7 Morgan, 1995, Clusterin expression by astrocytes is influenced by transforming growth factor β1 and heterotypic cell interactions, J Neuroimmunol, 58, 101, 10.1016/0165-5728(94)00194-S Lindholm, 1990, Transforming growth factor β-1 stimulates expression of nerve growth factor in the rat CNS, Neuro Report, 1, 9 Constam, 1992, Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes and microglia, J Immunol, 148, 1404, 10.4049/jimmunol.148.5.1404 da Cunha, 1992, Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytes, J Neuroimmol, 36, 157, 10.1016/0165-5728(92)90047-O Lindholm, 1992, Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation, J Cell Biol, 117, 395, 10.1083/jcb.117.2.395 Morganti-Kossmann, 1992, Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β, J Neuroimmol, 39, 163, 10.1016/0165-5728(92)90185-N Pousset, 1996, Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes, Mol Brain Res, 38, 54, 10.1016/0169-328X(95)00324-L Gagelin, 1995, Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: comparison with other factors and implications for cell motility, Glia, 13, 283, 10.1002/glia.440130405 Faber-Elman, 1996, Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation, J Clin Invest, 97, 162, 10.1172/JCI118385 Toru-Delbauffe, 1990, Effects of transforming growth factor β1 on astroglial cells in culture, J Neurochem, 54, 1056, 10.1111/j.1471-4159.1990.tb02357.x Labourdette, 1990, Transforming growth factor type β1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro, J Cell Biol, 144, 473 Xiao, 1996, Transforming growth factor-beta 1 (TGF-β1)-mediated inhibition of glial cell proliferation and downregulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-γ), Clin Exp Immunol, 103, 475, 10.1111/j.1365-2249.1996.tb08305.x Hunter, 1993, Transforming growth factor βs inhibit mitogen-stimulated proliferation of astrocytes, Glia, 7, 203, 10.1002/glia.440070303 Baghdassarian, 1993, Effects of transforming growth factor β1 on the extra-cellular matrix and cytoskeleton of cultured astrocytes, Glia, 7, 193, 10.1002/glia.440070302 Vergelli, 1995, Transforming growth factor-β1 inhibits the proliferation of rat astrocytes induced by serum and growth factors, J Neurosci Res, 40, 127, 10.1002/jnr.490400114 Silberstein, 1996, Cytokine-regulated expression of platelet-derived growth factor gene and protein in cultured human astrocytes, J Neurochem, 66, 1409, 10.1046/j.1471-4159.1996.66041409.x Johns, 1992, Transforming growth factor-β1 differentially regulates proliferation and MHC class 11 antigen expression in forebrain and brainstem astrocyte primary cultures, Brain Res, 585, 229, 10.1016/0006-8993(92)91211-V Solem, 1990, TGFβ regulates cystatin C in serum-free mouse embryo (SFME) cells, Biochem Biophys Res Comm, 172, 945, 10.1016/0006-291X(90)90767-H Panek, 1995, TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAKI, JAK2 or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor expression, J Immunol, 154, 610, 10.4049/jimmunol.154.2.610 Schluesener, 1990, Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen présentation and antagonize hyperinduction of class II major histo compatibility complex antigen expression by interferon-gamma and tumor necrosis factor alpha, J Neuroimmol, 27, 41, 10.1016/0165-5728(90)90134-9 Lee, 1997, TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibition of class II transactivator messenger RNA expression, J Immunol, 158, 2065, 10.4049/jimmunol.158.5.2065 Shrikant, 1996, Stimulus-specific inhibition of intercellular adhesion molecule-I gene expression by TGF-β1, J Immunol, 157, 892, 10.4049/jimmunol.157.2.892 Shrikant, 1994, Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1β, and interferon-β in astrocytes, J Neuroimmunol, 51, 209, 10.1016/0165-5728(94)90083-3 Hurwitz, 1992, Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes, J Exp Med, 176, 1631, 10.1084/jem.176.6.1631 Benveniste, 1994, Differential modulation of astrocyte cytokine gene expression by TGF-β1, J Immunol, 153, 5210, 10.4049/jimmunol.153.11.5210 Benveniste, 1995, Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-β, IL-6 and IL 10, Int J Dev Neurosci, 13, 341, 10.1016/0736-5748(94)00061-7 Aderka, 1989, IL-6 inhibits lipopolysaccharide induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice, J Immunol, 143, 3517, 10.4049/jimmunol.143.11.3517 Barnum, 1994, Transforming growth factor-β1 inhibits inflammatory cytokine induced C3 gene expression in astrocytes, J Immunol, 152, 765, 10.4049/jimmunol.152.2.765 Dawson, 1996, Nitric oxide neurotoxicity, J Clin Neuroanat, 10, 179, 10.1016/0891-0618(96)00148-2 Good, 1996, Evidence of neuronal oxidative damage in Alzheimer's disease, Am J Pathol, 149, 21 Hooper, 1997, Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis, 94, 2528 Bukrinsky, 1995, Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1(HIV-1) infected monocytes: implications for HIV-associated neurological disease, J Exp Med, 181, 735, 10.1084/jem.181.2.735 Hewett, 1993, Interferon-gamma and interleukin-β induce nitric oxide formation from primary mouse astrocytes, Neurosci Lett, 164, 229, 10.1016/0304-3940(93)90898-U Park, 1994, Modulation of inducible nitric oxide synthase expression in astroglial cells, Neuropharmacology, 33, 1419, 10.1016/0028-3908(94)90044-2 Vodovotz, 1996, Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse, J Exp Med, 183, 2337, 10.1084/jem.183.5.2337 Liu, 1996, Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1β and IL-1 receptor antagonist, J Immunol, 157, 3569, 10.4049/jimmunol.157.8.3569 Hu, 1995, Differential regulation by cytokines of human astrocyte nitric oxide production, Glia, 15, 491, 10.1002/glia.440150412 Davies, 1992, Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurons, Neurosci Lett, 140, 161, 10.1016/0304-3940(92)90092-L Shigeno, 1991, Amelioration of delayed neuronal death in the hippocampus by nerve growth factor, J Neurosci, 11, 2914, 10.1523/JNEUROSCI.11-09-02914.1991 Yamamoto, 1992, Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils, Neurosci Lett, 141, 161, 10.1016/0304-3940(92)90885-B Buchan, 1992, Nerve growth factor: pretreatment ameliorates ischemic hippocampal neuronal injury, Stroke, 21, 177 Hahn, 1994, The immortalized astroglial cell line RC7 is a new model system for the study of nerve growth factor regulation: stimulation by interleukin-1β and transforming growth factor-β1 is additive and affected differently by dibutyryl cyclic AMP, Glia, 10, 286, 10.1002/glia.440100407 Zafra, 1992, Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes, J Neurosci, 12, 4793, 10.1523/JNEUROSCI.12-12-04793.1992 Chao, 1992, Effects of transforming growth factor-β on murine astrocyte glutamine synthetase activity, J Clin Invest, 90, 1786, 10.1172/JCI116053 Hurwitz, 1995, Tumor necrosis factor alpha and transforming growth factor-β upregulate astrocyte expression of monocyte chemoattractant protein-1, J Neuroimmunol, 57, 193, 10.1016/0165-5728(95)00011-P Yao, 1990, Chemotaxis by a CNS macrophage, the microglia, J Neurosci Res, 27, 36, 10.1002/jnr.490270106 Hu, 1995, Cytokine modulation of murine microglial cell superoxide production, Glia, 13, 45, 10.1002/glia.440130106 Batuman, 1995, Differential regulation of transforming growth factor β1 gene expression by glucocorticoids in human T and glial cells, J Immunol, 155, 4397, 10.4049/jimmunol.155.9.4397 Chao, 1995, Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor β1 in murine microglial cell cultures, Clin Immunol Immunopathol, 77, 358, 10.1006/clin.1995.1163 Chao, 1995, Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines, Dev Neurosci, 17, 97, 10.1159/000111278 Suzumura, 1993, Transforming growth factor-β suppresses activation and proliferation of microglia in vitro, J Immunol, 151, 2150, 10.4049/jimmunol.151.4.2150 Chao, 1995, Modulation of human microglial cell superoxide production by cytokines, J Leuk Biol, 58, 65, 10.1002/jlb.58.1.65 Lodge, 1996, Regulation of microglial activation by TGF-β, IL-10 and CSF-1, J Leuk Biol, 60, 502, 10.1002/jlb.60.4.502 Panek, 1995, Class 11 MHC gene expression in microglia, J Immunol, 154, 2846, 10.4049/jimmunol.154.6.2846 Gehrmann, 1995, Reactive microglia in cerebral ischaemia: an early mediator of tissue damage, Neuropathol Appl Neurobiol, 21, 277, 10.1111/j.1365-2990.1995.tb01062.x Chao, 1996, Glia: the not so innocent bystanders, J Neurovirol, 2, 234, 10.3109/13550289609146886 McKinnon, 1993, A role for TGF-β in oligodendrocyte differentiation, J Cell Biol, 121, 1397, 10.1083/jcb.121.6.1397 Zola-Morgan, 1986, Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus, J Neurosci, 6, 2950, 10.1523/JNEUROSCI.06-10-02950.1986 Zola-Morgan, 1992, Enduring memory impairment in monkeys after ischemic damage to the hippocampus, J Neurosci, 12, 2582, 10.1523/JNEUROSCI.12-07-02582.1992 Ohno, 1996, Concurrent blockade of hippocampal metabotropic glutamate and N-methyl-D-aspartate receptors disrupts working memory in the rat, Neuroscience, 70, 303, 10.1016/0306-4522(95)00333-9 Ueki, 1996, Histological evidence for cholinergic alteration in the hippocampus following entorhinal cortex lesion, J Neurol Sci, 142, 7, 10.1016/0022-510X(96)00113-X Rami, 1993, Brain damage caused by ischemia: pathophysiological and pharmacological aspects, Dementia, 4, 21 Wilcox, 1988, Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain, J Neurosci, 8, 1901, 10.1523/JNEUROSCI.08-06-01901.1988 Heine, 1987, Role of transforming growth factor-β in the development of the mouse embryo, J Cell Biol, 105, 2861, 10.1083/jcb.105.6.2861 Klempt, 1992, Hypoxiaischemia induces transforming growth factor β1 mRNA in the infant rat brain, Mol Brain Res, 13, 93, 10.1016/0169-328X(92)90048-G Wang, 1995, Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia, Brain Res Bull, 36, 607, 10.1016/0361-9230(94)00243-T Wieβner, 1993, Expression of transforming growth factor-β1 and interleukin-β1 mRNA in rat brain following transient forebrain ischemia, Acta Neuropathol, 86, 439 Lehrmann, 1995, Cytokines in cerebral ischemia: expression of transforming growth factor beta-1 (TGF-/β1) mRNA in the postichemic adult rat hippocampus, Exp Neurol, 131, 114, 10.1016/0014-4886(95)90013-6 Krupinski, 1996, Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans, Stroke, 27, 852, 10.1161/01.STR.27.5.852 Gross, 1993, Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model, Stroke, 24, 558, 10.1161/01.STR.24.4.558 Gross, 1994, TGF-β1 post-treatment in a rabbit model of cerebral ischaemia, Neurol Res, 16, 465, 10.1080/01616412.1994.11740275 Prehn, 1993, Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neo-cortical cultures and protects mouse neocortex from ischemic injury in vivo, J Cereb Blood flow Metab, 13, 521, 10.1038/jcbfm.1993.67 Henrich-Noack, 1994, Neuroprotective effects of TGF-β, J Neural Transm, 43, 33 Henrich-Noack, 1996, TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia, Stroke, 27, 1609, 10.1161/01.STR.27.9.1609 Henrich-Noack, 1995, TGFβ1 protects hippocampal neurons from ischemic injury: evaluation of potential neuroprotective mechanisms, J Cereb Blood Flow Metab, 15, 5403 McNeill, 1994, Neuronal rescue with transforming growth factor β1 after hypoxic-ischaemic brain injury, Neuroreport, 5, 901, 10.1097/00001756-199404000-00012 Williams, 1995, The role of the growth factors IGF-1 and TGFβ1 after hypoxic-ischemic brain injury, Ann NY Acad Sci, 765, 306, 10.1111/j.1749-6632.1995.tb16592.x Lefer, 1990, Mediation of cardioprotection by transforming growth factor-β, Science, 249, 61, 10.1126/science.2164258 Roberts, 1993, Cardioprotective actions of transforming growth factor-β, Trends Cardiovasc Med, 3, 77, 10.1016/1050-1738(93)90027-4 Thomas, 1992, Transforming growth factor-β1 inhibits postischemic increases in splanchnic vascular resistance, Biotechnol Therap, 3, 91 Karasawa, 1991, Beneficial effects of transforming growth factor-β1 and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats, J Cardiovasc Pharmacol, 18, 95, 10.1097/00005344-199107000-00013 Lefer, 1993, Mechanism of the cardioprotective effect of transforming growth factor β1 in feline myocardial ischemia and reperfusion, 90, 1018 Riedel, 1996, Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory, Acta Physiol Scand, 157, 1, 10.1046/j.1365-201X.1996.484231000.x Miller, 1995, Roles of metabotropic glutamate receptors in brain plasticity and pathology, Ann NY Acad Sci, 757, 460, 10.1111/j.1749-6632.1995.tb17506.x Kaczmarek, 1997, Glutamate receptors in cortical plasticity: molecular and cellular biology, Physiol Rev, 77, 217, 10.1152/physrev.1997.77.1.217 Hollmann, 1994, Cloned glutamate receptors, Ann Rev Neurosci, 17, 31, 10.1146/annurev.ne.17.030194.000335 Richter, 1993, Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis, FEBS Lett, 325, 104, 10.1016/0014-5793(93)81423-W White, 1996, Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure, J Neurosci, 16, 5688, 10.1523/JNEUROSCI.16-18-05688.1996 Lu, 1996, Ca2+Permeable AMPA/Kainate and NMDA channels: high rate of Ca2+ influx underlies potent induction of injury, J Neurosci, 16, 5457, 10.1523/JNEUROSCI.16-17-05457.1996 Budd, 1996, Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells, J Neurochem, 67, 2282, 10.1046/j.1471-4159.1996.67062282.x Lu, 1995, Ca2+ permeable AMPA/kainate channels permit rapid injurious Ca2+ entry, NeuroReport, 6, 1089, 10.1097/00001756-199505300-00004 Wang, 1996, Seqestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons, J Neurophysiol, 76, 1611, 10.1152/jn.1996.76.3.1611 Weiss, 1994, AMPA/kainate receptor-mediated damage to NADPH-diaphorase-containing neurons is Ca2+ dependent, Neurosci Lett, 167, 93, 10.1016/0304-3940(94)91035-9 Isaev, 1996, Neurotoxic glutamate treatment of cultured cerebellar granule cells induces Ca2+ dependent collapse of mitochondrial membrane potential and ultrastructural alterations of mitochondria, FEBS Lett, 392, 143, 10.1016/0014-5793(96)00804-6 Prehn, 1996, Opposite effects of TGF-Jβ1 on rapidly and slowly triggered excitotoxic injury, Neurol Res, 35, 249 Choi, 1994, Glutamate receptors and the induction of excitotoxic neuronal death, Prog Brain Res, 100, 47, 10.1016/S0079-6123(08)60767-0 Ankarcrona, 1995, Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function, Neuron, 15, 961, 10.1016/0896-6273(95)90186-8 Bonfoco, 1995, Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D aspartate or nitric oxide/superoxide in cortical cell cultures, 92, 7162 Kaku, 1993, Neuroprotective effects of glutamate antagonists and extracellular acidity, Science, 260, 1516, 10.1126/science.8389056 Dingledine, 1994, Excitatory amino acid transmitters, 368 Williams, 1991, Modulation of the NMDA receptor by polyamines, Life Sci, 48, 469, 10.1016/0024-3205(91)90463-L Prehn, 1993, Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate, J Neurochem, 60, 165, 10.1111/j.1471-4159.1993.tb13389.x Prehn, 1994, Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β1 confers wide ranging protection on rat hippocampal neurons, 91, 12599 Prehn, 1996, Marked diversity in the action of growth factors on N-methyl-D-aspartate-induced neuronal degeneration, Eur J Pharmacol, 306, 81, 10.1016/0014-2999(96)00225-7 Tomoda, 1996, Transforming growth factor-β is a survival factor for neonate cortical neurons: coincident expression of type I receptors in developing cerebral cortices, Dev Biol, 179, 79, 10.1006/dbio.1996.0242 Murphy, 1996, Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria, 93, 9892 Marin, 1996, Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+, Oncogene, 12, 2259 Myers, 1995, Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability, J Neurochem, 65, 2432, 10.1046/j.1471-4159.1995.65062432.x Lawrence, 1996, Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo, J Neurosci, 16, 486, 10.1523/JNEUROSCI.16-02-00486.1996 Takenaka, 1992, Transforming growth factor-βl rapidly induces Hsp70 and Hsp90 molecular chaperones in cultured chicken embryo cells, J Cell Physiol, 152, 568, 10.1002/jcp.1041520317 Takenaka, 1993, Regulation of chicken Hsp70 and Hsp90 family gene expression by transforming growth factor-β1, J Cell Physiol, 155, 54, 10.1002/jcp.1041550108 Dawson, 1991, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, 88, 6368 Lefebvre, 1991, TGFβ1 modulates bFGF receptor message expression in cultured adult auditory neurons, NeuroReport, 2, 305, 10.1097/00001756-199106000-00001 Grothe, 1996, Fibroblast growth factor and its implications for developing and regenerating neurons, Acta Orthop Scand, 40, 403 Kane, 1996, Transforming growth factor-β3 increases NMDA receptor-mediated excitotoxicity in rat cerebral cortical neurons independently of glia, Neurosci Lett, 204, 93, 10.1016/0304-3940(96)12332-6 Prehn, 1994, Opposing effects of transforming growth factor-β1 on glutamate neurotoxicity, Neuroscience, 60, 7, 10.1016/0306-4522(94)90198-8 Koh, 1995, Potentiated necrosis of cultured cortical neurons by neurotrophins, Science, 268, 573, 10.1126/science.7725105 Cannella, 1995, The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann Neurol, 37, 424, 10.1002/ana.410370404 Woodroofe, 1993, Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization, Cytokine, 5, 583, 10.1016/S1043-4666(05)80008-0 Peress, 1996, Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2, and 3 isotypes in multiple sclerosis, J Neuroimmunol, 71, 115, 10.1016/S0165-5728(96)00135-X Link, 1994, Interferon-γ, interleukin-4 and transforming growth factor-β mRNA expression in multiple sclerosis and myasthenia gravis, Acta Neurol Scand, 5 Link, 1994, Increased transforming growth factor-β, interleukin-4 and interferon-gamma in multiple sclerosis, Ann Neurol, 36, 379, 10.1002/ana.410360309 Rieckmann, 1994, Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis, Neurology, 44, 1523, 10.1212/WNL.44.8.1523 Beck, 1991, TGF-β-like activity produced during regression of exacerbations in multiple sclerosis, Acta Neurol Scand, 84, 452, 10.1111/j.1600-0404.1991.tb04988.x Mokhtarian, 1994, Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis, J Immunol, 152, 6003, 10.4049/jimmunol.152.12.6003 Correale, 1995, Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis, J Immunol, 154, 2959, 10.4049/jimmunol.154.6.2959 Link, 1995, Transforming growth factor-β suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis, J Neuroimmol, 58, 21, 10.1016/0165-5728(94)00183-O Link, 1994, Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-β, J Neuroimmol, 49, 9, 10.1016/0165-5728(94)90175-9 Link, 1994, Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis, Ann Neurol, 35, 197, 10.1002/ana.410350211 Santambrogio, 1993, Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis, J Immunol, 151, 1116, 10.4049/jimmunol.151.2.1116 Issazadeh, 1995, Interferon gamma, interleukin 4 and transforming growth factor-β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells, J Neurosci Res, 40, 579, 10.1002/jnr.490400503 Johns, 1991, Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1, J Immunol, 147, 1792, 10.4049/jimmunol.147.6.1792 Racke, 1992, Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis, Int Immunol, 4, 615, 10.1093/intimm/4.5.615 Issazadeh, 1996, Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β, J Neuroimmol, 69, 103, 10.1016/0165-5728(96)00076-8 Tanuma, 1997, Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis, J Neuroimmol, 73, 197, 10.1016/S0165-5728(96)00199-3 Santambrogio, 1993, Antagonistic effects of endogenous and exogenous TGFβ and TNF on auto-immune diseases in mice, Immunopharmacol Imunotoxicol, 15, 461, 10.3109/08923979309035240 Kuruvilla, 1991, Protective effect of transforming growth factor -β1 on experimental autoimmune diseases in mice, 88, 2918 Racke, 1991, Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1, J Immunol, 146, 3012, 10.4049/jimmunol.146.9.3012 Stevens, 1994, Transforming growth factor-β1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis, J Neuroimmunol, 51, 77, 10.1016/0165-5728(94)90131-7 Racke, 1993, Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor β2, J Immunol, 46, 175 Santambrogio, 1995, Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis, J Neuroimmunol, 58, 211, 10.1016/0165-5728(95)00022-T Johns, 1993, Experimental allergic encephalomyelitis: neutralizing antibody to TGFβ1 enhances the clinical severity of the disease, J Neuroimmunol, 47, 1, 10.1016/0165-5728(93)90278-7 Weiner, 1997, Oral tolerance for the treatment of autoimmune diseases, Annu Rep Med, 48, 341, 10.1146/annurev.med.48.1.341 Inobe, 1995, In vivo administration of IL-4 induces TGF-β producing T cells and protects animals from experimental autoimmune encephalomyelitis Harbige, 1995, The protective effect of linoleic acid and gammalinoleic acid-rich lipid in EAE is associated with TGF-β1 production Mustafa, 1993, The major histocompatibility complex influences myelin basic protein 63–88 induced T cell cytokine profile and experimental autoimmune encephalomyelitis, Eur J Immunol, 23, 3089, 10.1002/eji.1830231207 Mustafa, 1994, Protective influences on experimental autoimmune encephalomyelitis by MHC Class I and Class II alleles, J Immunol, 153, 3337, 10.4049/jimmunol.153.7.3337 Mokhtarian, 1994, Immune responses, and autoimmune outcome, during virus infection of the central nervous system, Cell Immunol, 157, 195, 10.1006/cimm.1994.1216 Miller, 1992, Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering, 89, 421 Miller, 1993, Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression, J Immunol, 151, 7307, 10.4049/jimmunol.151.12.7307 Chen, 1995, Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression, J Immunol, 155, 910, 10.4049/jimmunol.155.2.910 Santos, 1994, Oral tolerance to myelin basic protein induces regulatory TGF-β secreting T cells in Peyer's patches of SJL mice, Cell Immunol, 157, 439, 10.1006/cimm.1994.1240 Fukaura, 1996, Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1 secreting Th3 T cells by oral administration of myelin in multiple sclerosis, J Clin Invest, 98, 70, 10.1172/JCI118779 Khoury, 1992, Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of transforming growth factor β interleukin 4, and prostaglandin E expression in the brain, J Exp Med, 176, 1355, 10.1084/jem.176.5.1355 Gamble, 1988, Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β, Science, 242, 97, 10.1126/science.3175638 Gamble, 1991, Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β1, J Immunol, 146, 1149, 10.4049/jimmunol.146.4.1149 McCarron, 1993, Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells, J Neuroimmol, 43, 23, 10.1016/0165-5728(93)90071-6 Fabry, 1995, TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo, J Immunol, 155, 325, 10.4049/jimmunol.155.1.325 Savage, 1997, Cell adhesion molecule expression within human glomerular and kidney organ culture, J Pathol, 181, 111, 10.1002/(SICI)1096-9896(199701)181:1<111::AID-PATH698>3.0.CO;2-9 Fabry, 1992, Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55, J Neuroimmol, 36, 1, 10.1016/0165-5728(92)90026-H Swerlick, 1991, Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells, J Invest Dermatol, 97, 190, 10.1111/1523-1747.ep12479643 Ransohoff, 1991, Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy, Arch Neurol, 48, 1244, 10.1001/archneur.1991.00530240048017 Ransohoff, 1991, Interferon-β specifically inhibits interferon gamma induced class 11 major histocompatibility complex gene transcription in a human astrocytoma cell line, J Neuroimmol, 33, 103, 10.1016/0165-5728(91)90054-B Kreutzberg, 1995, Microglia, the first line of defense in brain pathologies, Arzneimittelforschung, 45, 357 Devajyothi, 1993, Inhibition of interferon-γ-induced major histocompatiblity complex class II gene transcription by interferon-β and type β1 transforming growth factor in human astrocytoma cells, J Biol Chem, 268, 18794, 10.1016/S0021-9258(17)46698-1 Merrill, 1993, Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide, J Immunol, 151, 2132, 10.4049/jimmunol.151.4.2132 Zielasek, 1995, Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis, J Neuroimmunol, 58, 81, 10.1016/0165-5728(94)00192-Q Brosnan, 1994, Reactive nitrogen intermediates in human neuropathology: an overview, Dev Neurosci, 16, 152, 10.1159/000112102 Forstermann, 1994, Nitric oxide synthase isozymes, Hypertension, 23, 1121, 10.1161/01.HYP.23.6.1121 Shindo, 1994, Nitric oxide synthesis in rat cardiac myocytes and fibroblasts, Life Sci, 55, 1101, 10.1016/0024-3205(94)00238-X Perrella, 1994, Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells, J Biol Chem, 269, 14595, 10.1016/S0021-9258(17)36665-6 Chesrown, 1994, Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages, Biochem Biophys Res Comm, 200, 126, 10.1006/bbrc.1994.1424 Gilbert, 1993, Transforming growth factor-β differentially modulates the inducible nitric oxide synthase gene in distinct cell types, Biochem Biophys Res Comm, 195, 380, 10.1006/bbrc.1993.2054 Jun, 1995, Down-regulation of transforming growth factor-β gene expression by antisense oligodeoxynucleotides increases recombinant interferon-γ induced nitric oxide synthesis in murine peritoneal macrophages, Immunology, 85, 114 Merrill, 1991, Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFfl, Glia, 4, 327, 10.1002/glia.440040311 Koprowski, 1993, In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases, 90, 3024 Lin, 1993, Nitric oxide localised to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study, J Exp Med, 178, 643, 10.1084/jem.178.2.643 Van Dam, 1995, Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin, J Neurosci Res, 40, 251, 10.1002/jnr.490400214 Reiling, 1994, Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages, Eur J Immunol, 24, 1941, 10.1002/eji.1830240836 Tracey, 1994, Immunochemical detection of inducible NO synthase in human lung, Am J Physiol, 266, L722 Denis, 1994, Human monocytes/macrophages: NO or no NO?, J Leuk Biol, 123, 129 Bo, 1994, Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains, Ann Neurol, 36, 778, 10.1002/ana.410360515 Edwards, 1993, Pathogenesis of Parkinson's disease, Clin Neurosci, 1, 36 Chalazonitis, 1992, Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor, Dev Biol, 152, 121, 10.1016/0012-1606(92)90162-A Martinou, 1990, Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture, Dev Brain Res, 52, 175, 10.1016/0165-3806(90)90233-O Gouin, 1996, Transforming growth factor-β3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in different manners to promote motoneuron survival in vitro, J Neurosci Res, 43, 454, 10.1002/(SICI)1097-4547(19960215)43:4<454::AID-JNR6>3.0.CO;2-E Ishihara, 1994, Transforming growth factor-β1 and β2 promote neurite sprouting and elongation of cultured rat hippocampal neurons, Brain Res, 639, 21, 10.1016/0006-8993(94)91759-0 Krieglstein, 1994, Transforming growth factor β1 promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity, Neuroscience, 63, 1189, 10.1016/0306-4522(94)90583-5 Krieglstein, 1995, TGF-β superfamily members promote survival of mid-brain dopaminergic neurons and protect them against MPP+ toxicity, EMBO J, 14, 736, 10.1002/j.1460-2075.1995.tb07052.x Krieglstein, 1996, The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-β super family and characterization of the serum-free culture system, J Neural Transm, 47, 247, 10.1007/978-3-7091-6892-9_17 Unsicker, 1996, Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-β, 196, 70 Unsicker, 1996, Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-β, 196, 80 Poulsen, 1994, TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons, Neuron, 13, 1245, 10.1016/0896-6273(94)90062-0 Sauer, 1995, Glial cell linederived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion, 92, 8935 Mogi, 1995, Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease, Neurosci Lett, 193, 129, 10.1016/0304-3940(95)11686-Q Vawter, 1996, TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid, Exp Neurol, 142, 313, 10.1006/exnr.1996.0200 McKhann, 1984, Clinical diagnosis of Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Selkoe, 1994, Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease, Annu Rev Cell Biol, 10, 373, 10.1146/annurev.cb.10.110194.002105 Selkoe, 1994, Normal and abnormal biology of the β-amyloid precursor protein, Annu Rev Neurosci, 17, 489, 10.1146/annurev.ne.17.030194.002421 Frautschy, 1991, Effects of injected Alzheimer β-amyloid cores in rat brain, 88, 8362 Yankner, 1990, Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides, Science, 250, 279, 10.1126/science.2218531 Laferla, 1995, The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice, Nat Genet, 9, 21, 10.1038/ng0195-21 Bodmer, 1990, Transforming growth factor-β bound to soluble derivatives of the β amyloid precursor protein of Alzheimer's disease, Biochem Biophys Res Comm, 171, 890, 10.1016/0006-291X(90)91229-L van der Wal, 1993, Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies, NeuroReport, 4, 69, 10.1097/00001756-199301000-00018 Peress, 1995, Differential expression of TGF-β1, 2, and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains, J Neuropathol Exp Neurol, 54, 802, 10.1097/00005072-199511000-00007 Frautschy, 1996, Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits, Neurobiol Aging, 17, 311, 10.1016/0197-4580(95)02073-X Flanders, 1995, Altered expression of transforming growth factor-β in Alzheimer's disease, Neurology, 45, 1561, 10.1212/WNL.45.8.1561 Chao, 1994, Serum cytokine levels in patients with Alzheimer's disease, Clin Diagn Lab Immunol, 1, 433, 10.1128/CDLI.1.4.433-436.1994 Chao, 1994, Transforming growth factor β in Alzheimer's disease, Clin Diagn Lab Immunol, 1, 109, 10.1128/CDLI.1.1.109-110.1994 Gray, 1993, Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β astrocytes, Mol Brain Res, 19, 251, 10.1016/0169-328X(93)90037-P Morning, 1994, Transforming growth factor β mediates increase of mature transmembrane amyloid precursor protein in microglial cells, FEBS Lett, 342, 267, 10.1016/0014-5793(94)80514-8 Mattson, 1992, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J Neurol Sci, 12, 376 Wolozin, 1995, Transforming growth factor β induces Aβ responsive calcium fluxes in neurons, NeuroReport, 6, 1429, 10.1097/00001756-199507100-00017 Choi-Miura, 1996, Relationship between multifunctional protein “clusterin” and Alzheimer disease, Neurobiol Aging, 17, 717, 10.1016/S0197-4580(96)00106-6 Boggs, 1996, Clusterin (Apo J) protects against in vitro amyloid-β (1–40) neurotoxicity, J Neurochem, 67, 1324, 10.1046/j.1471-4159.1996.67031324.x Oda, 1995, Clusterin (apo J) alters the aggregation of amyloid β-peptide (Aβ 1–42) and forms slowly sedimenting Aβ complexes that cause oxidative stress, Exp Neurol, 136, 22, 10.1006/exnr.1995.1080 Chao, 1994, Transforming growth factor β protects human neurons against β-amyloid-induced injury, Mol Chem Neuropathol, 23, 159, 10.1007/BF02815409 Prehn, 1996, Protective effect of transforming growth factor-β1 on β-amyloid neuro-toxicity in rat hippocampal neurons, Mol Pharmacol, 49, 319 Ren, 1996, Transforming growth factors-β1 protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide, Brain Res, 732, 16, 10.1016/0006-8993(96)00458-1 Goodman, 1993, Secreted forms of βAPP protect hippocampal neurons against Aβ toxicity and oxidative injury, Soc Neurosci. Abs, 19, 1251 Kekow, 1990, Transforming growth factor β and non-cytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection, 87, 8321 Wahl, 1991, Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome, J. Exp Med, 173, 981, 10.1084/jem.173.4.981 Kekow, 1991, Transforming growth factor-β and suppression of humoral immune responses in HIV infection, J Clin Review, 87, 1010 Johnson, 1996, Distribution of transforming growth factor-β isoforms in human immunodeficiency virus-1 encephalitis, Hum Pathol, 27, 643, 10.1016/S0046-8177(96)90392-5 da Cunha, 1995, HIV-1 non-specifically stimulates production of transforming growth factor-β1 transfer in primary astrocytes, J Neuroimmunol, 60, 125, 10.1016/0165-5728(95)00062-7 Zauli, 1992, Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1 induced hematopoietic suppression, Blood, 80, 3036, 10.1182/blood.V80.12.3036.3036 Cupp, 1993, Evidence for stimulation of the transforming growth factor β promoter by HIV-1 Tat in cells derived from CNS, Oncogene, 8, 2231 Rasty, 1996, Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor β1 gene expression, 93, 6073 Lazdins, 1991, TGF-β: up-regulator of HIV replication in macrophages, Res Virol, 142, 239, 10.1016/0923-2516(91)90063-9 Lazdins, 1991, In vitro effect of transforming growth factor-β on progression on HIV-1 infection in primary mononuclear phagocytes, J Immunol, 147, 1201, 10.4049/jimmunol.147.4.1201 Poli, 1991, Transforming growth factor-β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage, J Exp Med, 173, 589, 10.1084/jem.173.3.589 Price, 1994, Understanding the AIDS dementia complex (ADC), 1 Masliah, 1996, In vivo modeling of HIV-1 mediated neurodegeneration, Am J Pathol, 149, 745 Benveniste, 1994, Cytokine circuits in brain, 72, 71 Yoshioka, 1995, Role of immune activation and cytokine expression in HIV-1 associated neurologic diseases, Adv Neuroimmunol, 5, 335, 10.1016/0960-5428(95)00012-Q Merrill, 1993, Cytokines in AIDS-associated nervous and immune system dysfunction, vol 17, 243 Wahl, 1987, Transforming growth factor β induces monocyte chemotaxis and growth factor production, 84, 5788 Wyss-Coray, 1995, Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1, Am J Pathol, 147, 53 Meucci, 1996, gpl20-Induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1, J Neurosci, 16, 4080, 10.1523/JNEUROSCI.16-13-04080.1996